Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

H Mohammad; K Madsen; O Graumann; A C Loya; N V Jensen; R H Dahlrot

doi:10.1016/j.eucr.2021.101880

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

H Mohammad^*, K Madsen, O Graumann, A C Loya, N V Jensen, R H Dahlrot

^*Corresponding author for this work

Pathology, Department of

Abstract

Metanephric Adenoma (MA) is a rare and unclassifiable renal tumour with sparse reported clinical and morphological features. Generally MA's have a benign course without recurrence after nephrectomy, however a few cases received oncological treatment due to malignant progression. We present a 42-year-old woman who years after an initial nephrectomy developed several processes and biopsy confirmed recurrence of MA. Sunitinib was given for only two weeks, as she developed side-effects and currently the patient undergoes control scans with only minimal growth of the processes. This is the first case of MA treated with Tyrosin-Kinase-Inhibitor.

Original language	English
Article number	101880
Journal	Urology case reports
Volume	40
ISSN	2214-4420
DOIs	https://doi.org/10.1016/j.eucr.2021.101880
Publication status	Published - Jan 2022

Access to Document

10.1016/j.eucr.2021.101880

Cite this

@article{5ed01f18fa044308ae2c5062a13e2e57,

title = "Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib",

abstract = "Metanephric Adenoma (MA) is a rare and unclassifiable renal tumour with sparse reported clinical and morphological features. Generally MA's have a benign course without recurrence after nephrectomy, however a few cases received oncological treatment due to malignant progression. We present a 42-year-old woman who years after an initial nephrectomy developed several processes and biopsy confirmed recurrence of MA. Sunitinib was given for only two weeks, as she developed side-effects and currently the patient undergoes control scans with only minimal growth of the processes. This is the first case of MA treated with Tyrosin-Kinase-Inhibitor.",

author = "H Mohammad and K Madsen and O Graumann and Loya, {A C} and Jensen, {N V} and Dahlrot, {R H}",

note = "{\textcopyright} 2021 The Authors. Published by Elsevier Inc.",

year = "2022",

month = jan,

doi = "10.1016/j.eucr.2021.101880",

language = "English",

volume = "40",

journal = "Urology case reports",

issn = "2214-4420",

publisher = "Elsevier Saunders",

}

TY - JOUR

T1 - Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

AU - Mohammad, H

AU - Madsen, K

AU - Graumann, O

AU - Loya, A C

AU - Jensen, N V

AU - Dahlrot, R H

PY - 2022/1

Y1 - 2022/1

N2 - Metanephric Adenoma (MA) is a rare and unclassifiable renal tumour with sparse reported clinical and morphological features. Generally MA's have a benign course without recurrence after nephrectomy, however a few cases received oncological treatment due to malignant progression. We present a 42-year-old woman who years after an initial nephrectomy developed several processes and biopsy confirmed recurrence of MA. Sunitinib was given for only two weeks, as she developed side-effects and currently the patient undergoes control scans with only minimal growth of the processes. This is the first case of MA treated with Tyrosin-Kinase-Inhibitor.

AB - Metanephric Adenoma (MA) is a rare and unclassifiable renal tumour with sparse reported clinical and morphological features. Generally MA's have a benign course without recurrence after nephrectomy, however a few cases received oncological treatment due to malignant progression. We present a 42-year-old woman who years after an initial nephrectomy developed several processes and biopsy confirmed recurrence of MA. Sunitinib was given for only two weeks, as she developed side-effects and currently the patient undergoes control scans with only minimal growth of the processes. This is the first case of MA treated with Tyrosin-Kinase-Inhibitor.

UR - http://www.scopus.com/inward/record.url?scp=85116666842&partnerID=8YFLogxK

U2 - 10.1016/j.eucr.2021.101880

DO - 10.1016/j.eucr.2021.101880

M3 - Journal article

C2 - 34692420

VL - 40

JO - Urology case reports

JF - Urology case reports

SN - 2214-4420

M1 - 101880

ER -

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

Abstract

Access to Document

Other files and links

Fingerprint

Cite this